APA (7th ed.) Citation

M, F., H, B., M, B., A, G., J, F., T, R., . . . PT, M. (2021). Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10). ACS medicinal chemistry letters, 12(8), 1283. https://doi.org/10.1021/acsmedchemlett.1c00273

Chicago Style (17th ed.) Citation

M, Fushimi, et al. "Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10)." ACS Medicinal Chemistry Letters 12, no. 8 (2021): 1283. https://doi.org/10.1021/acsmedchemlett.1c00273.

MLA (9th ed.) Citation

M, Fushimi, et al. "Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10)." ACS Medicinal Chemistry Letters, vol. 12, no. 8, 2021, p. 1283, https://doi.org/10.1021/acsmedchemlett.1c00273.